Durata Therapeutics, Inc.
Durata Therapeutics, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 2012, the company has rapidly established itself as a leader in developing innovative therapies for infectious diseases, particularly focusing on antibiotic resistance. With a commitment to addressing unmet medical needs, Durata has achieved significant milestones, including the successful launch of its flagship product, Dalvance (dalbavancin), which offers a unique, long-acting treatment option for skin infections.
Operating primarily in the US and expanding its reach globally, Durata Therapeutics is recognised for its dedication to research and development, positioning itself at the forefront of the fight against resistant pathogens. The company’s strategic focus on high-quality, effective treatments has garnered notable achievements, solidifying its reputation within the healthcare community.
+4 vs industry average
Durata Therapeutics, Inc.’s score of 42 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Durata Therapeutics, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Durata Therapeutics, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Durata Therapeutics, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Durata Therapeutics, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from AbbVie Inc.
Carbon Disclosure Project
Inherited from AbbVie Inc.The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project